PMID: 16639996Apr 28, 2006Paper

Variability of practice in anatomic pathology and its effect on patient outcomes

Seminars in Diagnostic Pathology
Stephen S Raab

Abstract

Variability in the delivery of medical care negatively affects patient outcomes and contributes to escalating health care costs. Such heterogeneity exists on geographic, provider-related, institutional, and financial levels. Efforts to reduce it have resulted in the development of evidence-based clinical practice guidelines that have been only inconsistently adopted. Testing patterns in anatomic pathology (AP) also manifest considerable inconsistency, further contributing to suboptimal health outcomes and increased costs. Test variability in AP can be identified in its clinician-dependent preanalytic aspect and in the analytic phase as well, including the gross prosection of specimens, their processing, and reporting formats. To address selected facets of these issues, pathologists have developed practice guidelines that generally are based on "expert" opinion, representing the weakest form of evidence. Interpretative variability in AP has been investigated in numerous published studies that have measuring the "kappa statistic." Few of those analyses have addressed the impact of diagnostic disagreement on patient care; in addition, proposed and effective methods to reduce interpretative variability have only rarely been included.

References

Dec 1, 1992·The American Journal of Surgical Pathology·S J SchnittD L Page
Jun 24, 1992·JAMA : the Journal of the American Medical Association·D C HadornA Diokno
Jul 1, 1990·Journal of General Internal Medicine·T J Wachtel, P O'Sullivan
Sep 1, 1990·Journal of General Internal Medicine·S J McPhee, J A Bird
Dec 1, 1990·Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association·M R Chassin
Aug 1, 1989·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·H SvanholmS Olsen
Nov 13, 1987·JAMA : the Journal of the American Medical Association·M R ChassinR H Brook
Jan 30, 1986·The New England Journal of Medicine·M R ChassinD H Solomon
Dec 14, 1973·Science·J Wennberg, Gittelsohn
Aug 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J L AbbruzzeseM N Raber
Jun 1, 1994·Spine·D C CherkinG Waddell
Jan 30, 1993·BMJ : British Medical Journal·A R GambleI O Ellis
May 23, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P A Gross
Jan 29, 1999·Archives of Pathology & Laboratory Medicine·E H Hammond, C C Compton
Jun 1, 1999·JAMA : the Journal of the American Medical Association·T M ShaneyfeltJ Rothwangl
Aug 6, 1999·Clinical Endocrinology·F N BennedbaekL Hegedüs
Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
Oct 28, 1999·Archives of Pathology & Laboratory Medicine·G M HutchinsR Hanzlick
Aug 3, 2000·Archives of Pathology & Laboratory Medicine·S S Raab
Mar 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A Kish, UNKNOWN Infectious Diseases Society of America
May 9, 2001·American Journal of Clinical Pathology·UNKNOWN Association of Directors of Anatomic and Surgical Pathology
Jan 5, 2002·Virchows Archiv : an International Journal of Pathology·W D Lawrence, UNKNOWN Association of Directors of Anatomic and Surgical Pathology
Jan 22, 2002·Archives of Pathology & Laboratory Medicine·Dana Marie GrzybickiStephen S Raab
Apr 23, 2002·JAMA : the Journal of the American Medical Association·Diane SolomonUNKNOWN Bethesda 2001 Workshop
Apr 23, 2002·JAMA : the Journal of the American Medical Association·Thomas C WrightUNKNOWN ASCCP-Sponsored Consensus Conference
Apr 30, 2003·Journal of Clinical Pathology·Th H van der KwastUNKNOWN Members of the pathology committee of the European Randomised Study of Screening for Prostate Cancer
May 15, 2003·JAMA : the Journal of the American Medical Association·Wim H J M VerstappenRichard P T M Grol
Sep 23, 2003·The Journal of Thoracic and Cardiovascular Surgery·Yves LacasseBruno Raby
Aug 4, 2004·Annals of Internal Medicine·Eric G NeilsonUNKNOWN Resource Utilization Committee
Nov 24, 2004·Clinics in Laboratory Medicine·Stephen S Raab

❮ Previous
Next ❯

Citations

Jun 19, 2013·BMJ Quality & Safety·Mark L Graber
Dec 20, 2011·American Journal of Clinical Pathology·Heather S CurrensStephen S Raab
Nov 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hardeep SinghLaura A Petersen
Feb 15, 2018·Current Atherosclerosis Reports·Ekaterina Bakradze, Ava L Liberman
Feb 24, 2007·Laboratory Investigation; a Journal of Technical Methods and Pathology·James M Crawford
Sep 8, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·P A CrossA D Lopes
Jun 30, 2019·FEBS Letters·Khalifa Mohammad HelalTamiki Komatsuzaki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.